Corporate information

Company type

Transforming the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics.

Funding rounds

Profile Country
Blue Bear Ventures


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials